Cyclosporin A renders target cells resistant to immune cytolysis
- 1 January 1991
- journal article
- Published by Wiley in European Journal of Immunology
- Vol. 21 (1) , 221-226
- https://doi.org/10.1002/eji.1830210133
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Perforin‐Dependent and ‐Independent Pathways of Cytotoxicity Mediated by LymphocytesImmunological Reviews, 1988
- Mechanism of Cytotoxicity by Natural Killer (NK) CellsAnnual Review of Immunology, 1986
- Mechanism of Lymphocyte-Mediated CytotoxicityAnnual Review of Immunology, 1985
- Effect of cyclosporin-A (CsA) on the ability of T lymphocyte subsets to inhibit the proliferation of autologous EBV-transformed B cellsInternational Journal of Cancer, 1985
- LYMPHOPROLIFERATIVE DISORDERS IN CARDIAC TRANSPLANT RECIPIENTS ARE MULTICLONAL LYMPHOMASThe Lancet, 1984
- Coupling of growth arrest and differentiation at a distinct state in the G1 phase of the cell cycle: GD.Proceedings of the National Academy of Sciences, 1982
- Cyclosporin A abrogates proliferation of T cells and generation of suppresser and cytotoxic T-Cell function induced by Epstein-Barr virusImmunobiology, 1981
- The price of immunotherapyCurrent Problems in Surgery, 1981
- Cyclosporin a inhibits the proliferative response and the generation of helper, suppressor and cytotoxic T-cell functions in the autologous mixed lymphocyte reactionCellular Immunology, 1981
- IDIOPATHIC CARDIOMYOPATHY, AGE, AND SUPPRESSOR-CELL DYSFUNCTION AS RISK DETERMINANTS OF LYMPHOMA AFTER CARDIAC TRANSPLANTATIONThe Lancet, 1978